Abstract
In our previous studies, doxorubicin-loaded polyisohexylcyanoacrylate nanoparticles have been proven to increase dramatically the antitumoral activity of the cytotoxic agent in metastasis-bearing mice. The experimental model consisted of metastases induced by i.v. inoculation of reticulosarcoma M 5076 cell suspension to C57BL/6 mice. The improved efficacy of the drug was noted in terms of either metastasis count or survival. Therefore, tissue-distribution studies of this drug delivery system within the metastatic liver after i.v. administration were undertaken to gain more insight into the mechanism of action. Doxorubicin measurements in healthy hepatic or neoplastic tissue were carried out together with histological examinations using transmission electron microscopy. These results demonstrated the hepatic tissue to be an efficient reservoir of the drug when it was injected associated with nanoparticles. Accumulation of biodegradable nanoparticles with associated doxorubicin in Kupffer cells created a gradient of drug concentration for a massive and prolonged diffusion of the free drug towards the neoplastic tissue.
MeSH Terms
Animals
Cyanoacrylates
Doxorubicin/administration & dosage,pharmacokinetics
Drug Carriers
Injections, Intravenous
Liver/metabolism
Liver Neoplasms, Experimental/metabolism
Lymphoma, Non-Hodgkin/metabolism
Mice
Mice, Inbred Strains
Microchemistry
Microscopy, Electron
Neoplasm Transplantation
Tissue Distribution
Chemicals
Cyanoacrylates
Drug Carriers
polyisohexylcyanoacrylate
Doxorubicin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Chiannilkulchai N
Laboratoire de Pharmacie galénique et Biopharmacie, URA CNRS 1218, Faculté de Pharmacie, Chatenay-Malabry, France.
Ammoury N
Caillou B
Devissaguet J P
Couvreur P
References (14)
14 references, click to expand
-
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
Cancer Res. 1984 Sep;44(9):3698-705
PMID: 6744286
-
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.
Cancer Res. 1982 Nov;42(11):4734-9
PMID: 7127308
-
Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma.
Cancer Drug Deliv. 1987;4(2):75-88
PMID: 3322541
-
Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.
Cancer Res. 1981 Apr;41(4):1271-80
PMID: 7011532
-
A murine ovarian tumor with unique metastasizing capacity.
Eur J Cancer. 1981 Jun;17(6):651-8
PMID: 7308262
-
Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.
Biochem Pharmacol. 1978 Jan 1;27(1):21-7
PMID: 619903
-
Liposomes as drug carriers in cancer chemotherapy.
Pharmacol Ther. 1984;24(2):207-33
PMID: 6379684
-
Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin.
Cancer Drug Deliv. 1983;1(1):43-58
PMID: 6544117
-
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.
Cancer Res. 1988 Mar 1;48(5):1300-6
PMID: 3342409
-
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
J Pharm Sci. 1982 Jul;71(7):790-2
PMID: 7120064
-
Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases.
Sel Cancer Ther. 1989;5(1):1-11
PMID: 2756244
-
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells.
J Pharm Sci. 1984 Jul;73(7):980-2
PMID: 6470966
-
Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.
Br J Cancer. 1985 May;51(5):681-9
PMID: 3994911
-
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
Cancer Res. 1987 Dec 15;47(24 Pt 1):6462-6
PMID: 3315188